New Two-Pronged attack tested for Tough-to-Treat bone cancer in young people
NCT ID NCT05019703
Summary
This study is testing a combination of two drugs, atezolizumab and cabozantinib, to see if they can help control advanced osteosarcoma (a type of bone cancer) in adolescents and young adults. The trial is for patients aged 12 and older whose cancer has come back or spread after standard treatments. Researchers want to see if this drug combo can help the immune system fight the cancer and slow its growth.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RECURRENT OSTEOSARCOMA are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
M D Anderson Cancer Center
RECRUITINGHouston, Texas, 77030, United States
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact
Conditions
Explore the condition pages connected to this study.